Skip to main content
. 2022 Mar 28;12:866357. doi: 10.3389/fcimb.2022.866357

Figure 5.

Figure 5

Cell surface morphologies of Xoo treated with polymyxin B1 and E2. (A) CK, (B) Xoo cells treated with polymyxin B1 (1 μg/mL), (C) Xoo cells treated with polymyxin B1 (5 μg/mL), (D) Xoo cells treated with polymyxin B1 (10 μg/mL), (E) Xoo cells treated with polymyxin E2 (1 μg/mL), (F) Xoo cells treated with polymyxin E2 (5 μg/mL), (G) Xoo cells treated with polymyxin E2 (10 μg/mL).